Viral epigenomes in human tumorigenesis

Oncogene
Agustin F Fernandez, Manel Esteller

Abstract

Viruses are associated with 15-20% of human cancers worldwide. In the last century, many studies were directed towards elucidating the molecular mechanisms and genetic alterations by which viruses cause cancer. The importance of epigenetics in the regulation of gene expression has prompted the investigation of virus and host interactions not only at the genetic level but also at the epigenetic level. In this study, we summarize the published epigenetic information relating to the genomes of viruses directly or indirectly associated with the establishment of tumorigenic processes. We also review aspects such as viral replication and latency associated with epigenetic changes and summarize what is known about epigenetic alterations in host genomes and the implications of these for the tumoral process. The advances made in characterizing epigenetic features in cancer-causing viruses have improved our understanding of their functional mechanisms. Knowledge of the epigenetic changes that occur in the genome of these viruses should provide us with markers for following cancer progression, as well as new tools for cancer therapy.

References

Feb 1, 1979·Journal of Virology·J E ShawC W Carter
Sep 1, 1985·The Journal of General Virology·P J Dyson, P J Farrell
Oct 9, 1987·Science·R Holliday
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszR C Gallo
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R H Miller, W S Robinson
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·Y HinumaI Miyoshi
Mar 1, 1996·Biological Chemistry Hoppe-Seyler·S PröschD H Krüger
Oct 15, 1996·Annals of Internal Medicine·A I ShararaJ D Hamilton
Aug 1, 1997·Trends in Genetics : TIG·J A YoderT H Bestor
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·R SunG Miller
Jun 22, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·V Colot, J L Rossignol
Nov 5, 1999·Seminars in Cancer Biology·R F AmbinderQ Tao
Nov 5, 1999·Annual Review of Microbiology·A RoulstonP E Branton
Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
Jun 14, 2000·Journal of Virology·Y C PengE J Androphy
Nov 18, 2000·Journal of the National Cancer Institute·UNKNOWN International Collaboration on HIV and Cancer
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·J ChenK Yamanishi
Aug 11, 2001·Science·P A Jones, D Takai
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Aug 23, 2002·Seminars in Cancer Biology·Andrew P FeinbergRolf Ohlsson
Jun 10, 2003·Microbiology and Molecular Biology Reviews : MMBR·Lyubomir A DourmishevDavid M Lukac
Jun 19, 2003·Oncogene·Nikita AvvakumovJoe S Mymryk
Oct 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Qian Tao, Keith D Robertson
Nov 1, 2003·Advances in Cancer Research·Hul Li, Janos Minarovits
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin

❮ Previous
Next ❯

Citations

Oct 9, 2013·Journal of Medicinal Chemistry·Fanny L CherblancMatthew J Fuchter
Jan 12, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shuji OginoEdward Giovannucci
Oct 12, 2013·Nature Reviews. Drug Discovery·Lorenzo GalluzziGuido Kroemer
Dec 21, 2011·Prostate Cancer and Prostatic Diseases·G GueronE Vazquez
Jul 1, 2011·Carcinogenesis·Dan DominissiniGideon Rechavi
Jun 12, 2013·Carcinogenesis·Zdenko HercegChristopher P Wild
Mar 27, 2012·Journal of the National Cancer Institute·Lisa MirabelloRobert D Burk
Jun 19, 2012·Clinical Epigenetics·Elzbieta PorebaAnna Gozdzicka-Jozefiak
May 16, 2015·Archives of Pathology & Laboratory Medicine·Nicole V J AnayannisThomas J Belbin
May 4, 2011·Reviews in Medical Virology·Michael NevelsChristina Paulus
Mar 30, 2011·International Journal of Cancer. Journal International Du Cancer·Felix Hoppe-Seyler, Karin Hoppe-Seyler
Jun 7, 2013·International Journal of Cancer. Journal International Du Cancer·Katerina M AntoniouGeorge Sourvinos
Feb 21, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jinchuan FangSufang Jin
Feb 11, 2011·Gynecologic Oncology·Chang SunRobert D Burk
Dec 6, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Gisele M VasconcelosJoseph L Wiemels
Jul 23, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Gareth A WilsonStephan Beck
Oct 12, 2010·Biochemical and Biophysical Research Communications·Chia-Chen HsuShu-Huei Hsiao
Sep 4, 2012·Clinical Epigenetics·Kathleen P SaavedraJuan Carlos S Roa
May 27, 2016·International Journal of Clinical Oncology·Joacilda da Conceição NunesEmanuel Sávio Cavalcanti Sarinho
Sep 2, 2016·Seminars in Cell & Developmental Biology·Thomas R PisanicTza-Huei Wang
May 2, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shrinka SenSharmila Sengupta
Sep 2, 2017·Viruses·David SotoMargaret E McLaughlin-Drubin
Jul 26, 2017·Oxidative Medicine and Cellular Longevity·Mankgopo Magdeline KgatleHenry Norman Hairwadzi
Dec 30, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew FeberJohn D Kelly
Sep 22, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ana GradissimoRobert D Burk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.